← Leaderboards
Marco B Mielcarek
Fred Hutchinson Cancer Research Center
$5,038,080
Attributed
$5,038,080
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $614.8K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,038,080 · 3
By mechanism
U19$2,233,350 · 1
R01$2,163,480 · 1
K08$641,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Rainer F. Storb$23,835,935
- Brenda Marie Sandmaier$22,185,663
- George Earl Georges$15,152,269
- David G Maloney$3,575,748
- John M. Pagel$5,647,981
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventT-LymphocyteCanis FamiliarisAllogenicStem CellsBaseIn Vitro AssayImmunosuppressive AgentsExposure ToMarrowProtective EffectConditioningPharmaceutical PreparationsTranslatingMalignant NeoplasmsImmuneMediatingGraft-Versus-Tumor InductionGraft-Vs-Host DiseaseCyclosporineGraft RejectionHematopoieticNatural ImmunosuppressionTransplantation
Grant awards (15)
Statins for Prevention of GVHD$433,400
R01 · FY2015 · HL · contact PI
Statins for Prevention of GVHD$431,200
R01 · FY2014 · HL · contact PI
Statins for Prevention of GVHD$418,880
R01 · FY2013 · HL · contact PI
Statins for Prevention of GVHD$440,000
R01 · FY2012 · HL · contact PI
Statins for Prevention of GVHD$440,000
R01 · FY2011 · HL · contact PI
Cell therapy for transient hematopoietic recovery$472,827
U19 · FY2009 · AI · contact PI
Cell therapy for transient hematopoietic recovery$464,175
U19 · FY2008 · AI · contact PI
Cell therapy for transient hematopoietic recovery$486,575
U19 · FY2007 · AI · contact PI
Optimizing Nonmyeloablative Stem Cell Transplantation$128,250
K08 · FY2007 · DK · contact PI
Cell therapy for transient hematopoietic recovery$477,081
U19 · FY2006 · AI · contact PI
Optimizing Nonmyeloablative Stem Cell Transportation$128,250
K08 · FY2006 · DK · contact PI
Cell therapy for transient hematopoietic recovery$332,692
U19 · FY2005 · AI
Optimizing Nonmyeloablative Stem Cell Transportation$128,250
K08 · FY2005 · DK
Optimizing Nonmyeloablative Stem Cell Transportation$128,250
K08 · FY2004 · DK
Optimizing Nonmyeloablative Stem Cell Transplantation$128,250
K08 · FY2003 · DK